# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-19-017683
Filing Date
2019-09-11
Accepted
2019-09-11 08:33:49
Documents
22
Period of Report
2019-09-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | f8k091119_wizepharma.htm | 8-K | 21351
2 | CORPORATE PRESENTATION | f8k091119ex99-1_wize.htm | EX-99.1 | 32148
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 91089
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 481724
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 130520
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 122332
7 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 259216
8 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 181608
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 112428
10 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 203082
11 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 235465
12 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 129456
13 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 104162
14 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 101817
15 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 194998
16 | GRAPHIC | ex99-1_014.jpg | GRAPHIC | 181818
17 | GRAPHIC | ex99-1_015.jpg | GRAPHIC | 147668
18 | GRAPHIC | ex99-1_016.jpg | GRAPHIC | 126334
19 | GRAPHIC | ex99-1_017.jpg | GRAPHIC | 256237
20 | GRAPHIC | ex99-1_018.jpg | GRAPHIC | 169685
21 | GRAPHIC | ex99-1_019.jpg | GRAPHIC | 126664
22 | GRAPHIC | ex99-1_020.jpg | GRAPHIC | 78709
| Complete submission text file | 0001213900-19-017683.txt |  | 4602767

Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52545 | Film No.: 191087189
SIC: 2834 Pharmaceutical Preparations